Survey on Anemia Therapy in Participants With Chronic Kidney Disease (CKD) Not on Dialysis

Roche

Status: Completed

Conditions: Chronic Kidney Diseases

Treatments: Other: Satisfaction Survey Questionnaire; Drug: ESA

Study type: Observational

Funder types: Industry

Identifiers

NCT02238067

ML25473

Details and patient eligibility

About

This study is a prospective, non-interventional, cross-sectional multicenter survey. The aim is to better understand the current therapy pattern for anemia in CKD treated with erythropoiesis-stimulating agents (ESAs) and not on-dialysis participant population in Israel. Participating physicians will be requested to interview eligible participants with CKD not on dialysis and to complete for them a satisfaction survey for anemia treatment. The survey will be completed twice, once at study start and once at six months' follow-up.

Enrollment: 196 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult participants with CKD Stage 3-5
• Treated with ESAs
• Participant is speaking the same language as the investigator interviewer

Exclusion criteria

• Past or current treatment with dialysis

Trial design

196 participants in 1 patient group

Chronic Renal Anemia Participants

Description:

Participants with CKD who are not on dialysis and treated with ESA according to the usual standard of care and best practice guidelines, will be interviewed by physician who will complete the satisfaction surveys on anemia treatment at baseline and at 6 months follow-up visit.

Treatment:

Other: Satisfaction Survey Questionnaire

Drug: ESA